SMTI Stock Analysis: Buy, Sell, or Hold?
SMTI - Sanara MedTech Inc. Common Stock
$24.84
0.57 (2.35%)
▲
5d:
+7.44%
30d:
+16.84%
90d:
+44.0%
BUY
MODERATE Confidence
Analysis Updated: Jul 2, 2026 12:00 AM ET
Earnings: Aug 12, 2026
Get Alerted When SMTI Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: SMTI shows positive signals but monitor for confirmation. Market pricing in 9.8% annual growth which appears achievable. Moderate conviction.
💡 BUY OPPORTUNITY: SMTI shows positive signals but monitor for confirmation. Market pricing in 9.8% annual growth which appears achievable. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$26.29
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$16.32
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: SMTI is currently trading at $24.84, which is considered extended relative to its 30-day fair value range of $21.53 to $23.67. From a valuation perspective, the stock is trading at a premium (Forward PE: 46.0) compared to its historical average (34.7). At these levels, the market is pricing in 9.8% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, SMTI is showing sideways momentum. The price is approaching resistance at $23.92. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: SMTI has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $34.33 (+38.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, SMTI is showing sideways momentum. The price is approaching resistance at $23.92. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: SMTI has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $34.33 (+38.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$21.53 -
$23.67
Company Quality Score
60/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
61.0%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 38.2% below Wall St target ($34.33)
- NEUTRAL: Trading at premium valuation - market expects 9.8% growth which is achievable
Trading Range Analysis
30-Day Trading Range
$21.53 -
$23.67
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$20.91
Resistance Level
$23.92
Current Trend
Sideways
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
46.00
Wall Street Target
$34.33
(+38.2%)
Revenue Growth (YoY)
18.6%
Profit Margin
-31.2%
Valuation Premium vs History
+9.8% premium
PE vs Historical
46.0 vs 34.7
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+9.8%
(market-implied from PE analysis)
1-Year Target
$27.27
(+10%)
2-Year Target
$29.95
(+21%)
3-Year Target
$32.88
(+32%)
3-Yr Target (if PE normalizes)
(PE: 46→35)
PE COMPRESSION
$24.80
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 46.0, Growth: 200.0%)
$83.84
(+238%)
Base:
(SPY PE: 21.8, Growth: 200.0%)
$39.69
(+60%)
Bear:
(PE: 18.5, Growth: 200.0%)
$33.74
(+36%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (152x PE), but valuation improves significantly next year (46x PE) as earnings recover.
Forward PE: 151.52 | Forward EPS (Implied): $0.16
Bull Case
$29.99
(+21%)
Analyst growth 15.0%, PE expands to 159.1
Base Case
$24.84
(0%)
Market implied 0.0%, PE stable at 151.5
Bear Case
$19.00
(-24%)
Severe decline -15.0%, PE contracts to 136.4
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: July 04, 2026 9:59 PM ET
Data refreshes hourly during market hours. Next update: 10:59 PM
Data refreshes hourly during market hours. Next update: 10:59 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SMTI showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Instruments & Supplies Stocks
Top-rated stocks in Medical Instruments & Supplies by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ISRG
Intuitive Surgical Inc |
BUY
33 analysts |
$565 | 65 BUY |
|
ALC
Alcon AG |
STRONG BUY
27 analysts |
$88 | 60 HOLD |
|
RMD
ResMed Inc |
BUY
19 analysts |
$261 | 67 BUY |
|
RGEN
Repligen Corporation |
STRONG BUY
19 analysts |
$176 | 56 HOLD |
|
WST
West Pharmaceutical Serv… |
STRONG BUY
13 analysts |
$359 | 64 BUY |
